Abbott MediaRoom abbott.mediaroom.com

Abbott to highlight expanding cancer diagnostic portfolio and clinical evidence at Digestive Disease Week (DDW) 2026

abbott.mediaroom.com·2w

Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform

abbott.mediaroom.com·2w

Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026

abbott.mediaroom.com·3w

New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

abbott.mediaroom.com·4w

Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

abbott.mediaroom.com·4w

New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health

abbott.mediaroom.com·5w

Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform

abbott.mediaroom.com·6w

Abbott hosts conference call for first-quarter earnings

abbott.mediaroom.com·7w

John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening

abbott.mediaroom.com·7w

Abbott completes acquisition of Exact Sciences

abbott.mediaroom.com·7w

Abbott acquisition of Exact Sciences set to close on March 23, 2026

abbott.mediaroom.com·8w

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

abbott.mediaroom.com·9w

New study data from Abbott show diabetic ketoacidosis on the rise – and many people still aren’t checking ketones

abbott.mediaroom.com·9w

Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'

abbott.mediaroom.com·9w

Abbott’s next‑generation CardioMEMS™ remote heart failure monitoring reader receives FDA approval to enhance patient experience and help detect disease progress...

abbott.mediaroom.com·11w

Abbott declares 409th consecutive quarterly dividend

abbott.mediaroom.com·12w

Late-breaking data show positive safety outcomes and closure rates for new Abbott device designed to reduce stroke risk in non-valvular AFib patients

abbott.mediaroom.com·14w

Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation

abbott.mediaroom.com·14w

Five-year data shows Abbott neuromodulation systems reduce healthcare visits related to pain and deliver sustained relief

abbott.mediaroom.com·16w

Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook

abbott.mediaroom.com·16w

Log in to enable infinite scrolling